UK Drug Pricing Scheme Talks Collapse: Industry Braces For Another Year Of High Rebates

The UK government and the pharma industry were unable to reach an agreement on changes to the country's voluntary pricing scheme (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Government Payers

More from United Kingdom